Ardelyx Inc
NASDAQ:ARDX

Watchlist Manager
Ardelyx Inc Logo
Ardelyx Inc
NASDAQ:ARDX
Watchlist
Price: 5.2 USD 1.36% Market Closed
Market Cap: 1.2B USD

EV/EBIT
Enterprise Value to EBIT

-29.8
Current
-20.9
Median
5
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-29.8
=
Enterprise Value
1.2B USD
/
EBIT
-39.6m USD
EBIT Growth EV/EBIT to Growth
US
Ardelyx Inc
NASDAQ:ARDX
Average EV/EBIT: 18.8
Negative Multiple: -29.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 128.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -560 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.9
17%
1.2
AU
CSL Ltd
ASX:CSL
23.3
14%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.4
11%
1.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -301.1 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-21.3
2-Years Forward
EV/EBIT
20.6
3-Years Forward
EV/EBIT
5.9